- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
IntraLase unveils 30 kHz laser
Washington, DC — The new IntraLase FS3 laser and upgrade for existing IntraLase customers increases the speed of the laser to 30 kHz from its current 15 kHz, allowing for faster procedure time, tighter spot placement, and lower energy.
April 17 - Washington, DC - The new IntraLase FS30 laser and upgrade for existing IntraLase customers increases the speed of the laser to 30 kHz from its current 15 kHz, allowing for faster procedure time, tighter spot placement, and lower energy.
The IntraLase FS laser was commercially introduced in 2002 as the first laser available for creating corneal flaps. The laser's unsurpassed precision has now extended its use to new therapeutic applications, specifically the treatment of diseased corneas, the company said in a prepared statement.
The IntraLase laser is so uniquely sensitive to corneal physiology that it is also approved for anterior lamellar keratoplasty and intrastromal ring implantation surgeries, which like LASIK benefit from customized architecture and unsurpassed accuracy, according to the company.
For more information on the IntraLase FS30 laser or to view a live demonstration, please visit IntraLase at ASCRS booth #1005.
